FORWARD FEATURES CALENDAR

Funds

Ancala Partners acquires majority stake in Holmleigh Care Group

Ancala Partners (Ancala), an independent infrastructure investment manager, has acquired a majority interest in UK care organisation Holmleigh Care Homes Limited (Holmleigh), on behalf of its European Infrastructure Fund II (Fund II).  Ancala has partnered with Holmleigh’s founders Rod Correia (Managing Director), and Matt Western, (Commercial Director), (together, ‘Founder Managers’) who

Edison Partners completes sale of Solovis to Nasdaq

Edison Partners, a growth-equity investment firm, has completed the sale of its stake in Solovis to Nasdaq (Nasdaq: NDAQ), generating over a 50 per cent IRR on its USD13 million total investment.Headquartered in Dallas, Solovis offers multi-asset class portfolio management, analytics and reporting tools for asset owners and allocators. Solovis’

Building site

Thoma Bravo to acquire Command Alkon from Quilvest

US-based private equity firm Thoma Bravo has agreed to acquire Command Alkon from its current owner Quilvest Capital Partners.  Command Alkon supplies collaboration platforms for construction’s heavy work, focused on the software and technology-enabled services sectors. “This agreement is a testament to Command Alkon’s sustained growth, leading market position, and

Resolute Capital Partners invests in PLUM Lending

Private Equity firm Resolute Capital Partners (RCP) has joined Elliott Management, a hedge fund manager, and Soft Bank, a  high-tech funding firm, by investing in PLUM Lending (PLUM). Earlier this month, RCP completed a USD2 million equity investment in PLUM through its technology fund, Strategic Technology Assets II (STA II). STA II

Medical staff

Haniel becomes cornerstone investor in Gilde Healthcare V

German family-equity company Haniel has become a regional cornerstone investor of Gilde Investment Management’s Gilde Healthcare V fund. The growth capital fund focuses on healthcare sectors including digital health, medtech and therapeutics, both in Europe and North America.  The fund will have a special focus on private healthcare companies enabling

Tokyo

With many PE deals on hold, when will confidence improve?

As an asset class with a buy-to-sell cycle that typically lasts around five to seven years, you would be forgiven for thinking that private equity could weather the storm of Covid-19 more smoothly than other, more inherently volatile asset classes, can. That’s partly true.

Gemspring Capital closes second fund at USD750m

Gemspring Capital, a lower middle-market private equity firm, has closed its second fund, Gemspring Capital Fund II (Fund II), with USD750 million of capital commitments.Gemspring secured commitments for Fund II from a globally diversified investor base comprised of leading endowments, foundations, family offices, consultants, insurance companies, pension plans and funds

Events

12 November, 2026 – 5:00 pm

Directory Listings